Dupixent® is the first and only biologic approved for adults living with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by elevated blood eosinophiles – and the first new treatment option… Read More
FRANKLIN LAKES, N.J. – BD (Becton, Dickinson and Company), a leading global medical technology company, announced a new self-collection solution for HPV testing in markets outside the United States. This… Read More
With the approval of ABRYSVO® for adults aged 18+, there is now a way to help protect against RSV in a population that previously did not have vaccination options. Pfizer… Read More
MISSISSAUGA ON – Dalhousie University, in collaboration with Nova Scotia Health’s INSPIRED COPD Outreach Program, the Nova Scotia Health Innovation Hub and the LungNSPEI, is proud to announce the upcoming launch… Read More
EUDRACAP® colon now available for clinical and commercial use First functional, ready-to-fill capsule targeting the ileo-colonic region Showcasing innovations for oral and parenteral drug delivery at CPHI Frankfurt Evonik’s EUDRACAP®… Read More
